A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers by unleashing a potent interferon-driven immune surge that transforms resistant tumors into immunotherapy-ready…

A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers by unleashing a potent interferon-driven immune surge that transforms resistant tumors into immunotherapy-ready…